Primary mouse neurons treated with both 100 nM C5a and 5 μM fibrillar amyloid beta (fAβ), to model what occurs in the AD brain, showed increased MAP-2 loss relative to either C5a or fAβ alone. The gene discussed is MAP2; the disease is Alzheimer disease.